Back to results
US 2004/0023937 A1Published application
Anti-cancer formulation
AssigneeGreystone Medical Group, Inc.
InventorStephen H. Monroe
Life of this patent
Estimating the term…
Abstract
Composition for halting the metastasis of cancer cells comprising rubidum ursolate. The rubidium ursolate is formed from a mixture of rubidium and ursolic acid obtained from the bark of the Virburnum plant.
Claims7
A composition for halting the metastasis of cancer cells comprising pharmaceutically effective amounts of rubidium ursolate.
A method for halting the metastasis of cancer cells comprising administration to a patient in need thereof of a pharmaceutically effective amount of rubidium ursolate.
Dependencies are inferred from the claim text.